Creatinine Test Companies

Disclaimer: List of key companies in no particular orderLatest Creatinine test Companies Update

• 
  Aug 2023: According to Mindray Bio-Medical Electronics, the Chinese medical equipment manufacturer would invest EUR145 million (USD159 million) in buying a controlling stake in DiaSys Diagnostic Systems and increase the German company's capital. This move will enhance the Chinese company's international business structure and product competitiveness. The parent company of Mindray Medical Netherlands, located in Shenzhen, announced late yesterday that it had signed two agreements with Gorka Holding, a shareholder in DiaSys Diagnostic, to purchase 75% of the firm's in-vitro diagnostics services and goods for EUR115 million in cash on July 29. Gorka will keep the remainder. It further stated that Mindray and Gorka would contribute EUR40 million (USD43.9 million) to the capital expansion of DiaSys Diagnostic, with the Chinese company contributing EUR30 million. According to Mindray, the acquisition will help it develop medium- and large-volume sample clients, bring in a top international team for in-vitro diagnostics, strengthen product competitiveness, and improve collaboration between its in-vitro testing, quality assurance, and calibration products.

• Abbott Laboratories


• Abcam Plc


• Acon Laboratories, Inc.


• Nova Biomedical Corporation


• Quest Diagnostic


• Siemens AG


• Thermo Fisher Scientific Inc.


• Roche


• Danaher Corporation.